Drospirenone - Leon Farma

Drug Profile

Drospirenone - Leon Farma

Alternative Names: DRSP-only oral contraceptive - Leon Farma; LF-111

Latest Information Update: 31 Aug 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Leon Farma
  • Class Androstenes; Antiandrogens; Oral contraceptives; Progesterone congeners
  • Mechanism of Action Mineralocorticoid receptor antagonists; Progesterone receptor agonists; Testosterone congener inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Pregnancy

Most Recent Events

  • 31 Aug 2018 Phase III clinical development is ongoing in Pregnancy (In adolescents, In adults, Prevention) in USA (PO) (NCT02269241)
  • 17 Mar 2017 No recent reports on development identified - Phase-III for Pregnancy (Prevention) (In adolescents) in Sweden, Germany and Finland (PO)
  • 17 Mar 2017 No recent reports on development identified - Phase-III for Pregnancy (Prevention) (In adolescents, In adults) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top